The founding team is made up of Yale, DreamWorks, and Hyperloop One alums in conjunction with a world-class clinical team at University of Pittsburgh Medical Center and USC. Flowly has also been studied in NIH-backed clinical trials that show an average 40% reduction in opioid usage. Flowly is backed by Y Combinator and has been featured by Inc., People, US Pain Foundation and more.